Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for RHHBY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 2005. Start Trial.
Date Value
May 31, 2026 40.92%
April 30, 2026 40.92%
March 31, 2026 40.92%
February 28, 2026 40.92%
January 31, 2026 40.92%
December 31, 2025 40.92%
November 30, 2025 40.92%
October 31, 2025 40.92%
September 30, 2025 40.92%
August 31, 2025 40.92%
July 31, 2025 40.92%
June 30, 2025 40.92%
May 31, 2025 40.92%
April 30, 2025 40.92%
March 31, 2025 40.92%
February 28, 2025 40.92%
January 31, 2025 40.92%
December 31, 2024 40.92%
November 30, 2024 40.92%
October 31, 2024 40.92%
September 30, 2024 40.92%
August 31, 2024 40.92%
July 31, 2024 40.92%
June 30, 2024 40.92%
May 31, 2024 40.92%
Date Value
April 30, 2024 39.79%
March 31, 2024 37.89%
February 29, 2024 37.89%
January 31, 2024 37.29%
December 31, 2023 37.29%
November 30, 2023 37.29%
October 31, 2023 37.29%
September 30, 2023 34.52%
August 31, 2023 34.52%
July 31, 2023 34.52%
June 30, 2023 34.52%
May 31, 2023 34.52%
April 30, 2023 34.52%
March 31, 2023 34.52%
February 28, 2023 32.54%
January 31, 2023 28.50%
December 31, 2022 28.50%
November 30, 2022 28.50%
October 31, 2022 28.50%
September 30, 2022 28.50%
August 31, 2022 28.50%
July 31, 2022 28.50%
June 30, 2022 28.50%
May 31, 2022 26.01%
April 30, 2022 24.19%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Novartis AG 20.42%
Eli Lilly & Co. 34.47%
Pfizer Inc. 58.95%
GSK Plc 39.39%
Johnson & Johnson 18.44%